Mengjun Wang, MD, MS

Research Professor / IACUC Chair

Dr. Mengjun Wang has 20+ years of experiences in in-vivo efficacy/safety studies of cardiovascular devices/pharmaceuticals. He worked at the Henry Ford Heart & Vascular Institute in Michigan for 12 years before moving to San Diego. His work fully focused on understanding the pathophysiology of heart failure, and the development and testing of novel therapeutic modalities for the treatment and prevention of heart failure and other cardiovascular diseases. He has extensive hands-on experience in pre-clinical cardiovascular device studies with large animals and strong expertise in performing cardiovascular interventions/surgery. Currently, he is committed to translational research on novel technologies and methods for the prevention, diagnosis, and treatment of cardiovascular diseases such as heart failure, myocardial infarction, and arrhythmia. Dr. Wang obtained his MD and MS degrees from Hebei Medical University and Peking University in China and was a highly trained surgeon before moving to the USA. He received research training at Peking University, Creighton University and University of North Carolina at Chapel Hill. He also earned a MS degree in Medical Informatics from the University of Nebraska at Omaha.